Drug Target Review: Advancing Muscle Repair

In the News 10.10.2023

Specialized muscle cells possess the ability to divide in a way that promotes muscle repair and regeneration. Discovering key regulatory elements of this process and molecules to enhance it has been the core work of Satellos, a company pioneering novel small-molecule medicines for Duchenne muscle dystrophy and other muscle disorders. In this exclusive interview, Frank Gleeson, Cofounder and CEO of Satellos, explores further.

Click here to view a pdf of the article.

In The News